Loading
Thermo Fisher Scientific Inc. Stock: price and insider trades · United States
Insider Decl.
2,318
Thresholds
n/a
Buy Volume
€12,245
3 ops. · all time
Sell Volume
€1B
1158 ops. · all time
Who traded when
BuySaleMarc N. Casper172 sales
Pettiti Gianluca8 sales
Lagarde Michel5 sales
Shafer Michael D5 sales
Lisa P. Britt4 sales
Joseph R. Holmes3 sales
+2 other insiders
Since the insiders bought
- -3.6%Entry US$535.55 · Close at T+365 US$516.44
- +20.7%Entry US$496.13 · Close at T+365 US$598.85
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Thermo Fisher Scientific Inc. Strong Buy (bullish), based on 26 analysts. Average price target: US$690.62.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 13,582 of 26,289 companies
50.5
score / 100
Value39
Quality62
FCF yld2.5%
Earn yld2.7%
EV/EBITDA25.1x
ROE13%
Gross mgn41%
Net mgn15%
Debt/EBITDA3.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$687.37
Analyst consensus
26 analystsStrong buy
US$560.00Target US$690.62(+0%)US$800.00
Income statement
RevenueUS$44.6B
Gross profitUS$18.2B41% margin
EBITDAUS$11.5B26% margin
Net incomeUS$6.7B15.0% margin
Valuation
PER (trailing)37.0x
PER (forward)24.9x
P/Book4.8x
Beta0.88
Balance sheet & cash
Market capUS$254.2B
Total debtUS$39.4B
Free Cash FlowUS$6.3B
Debt / Equity81%
Profitability & ownership
ROE13.5%
ROA5.1%
% insiders0.1%
% institutions94.0%
Last declaration on 1 September 2026
Declarations2,318 total
37.23 shares@ US$622.180.0000% mcap12.3% of flowCommon StockSEC:0000097745-26-000166:0
87.03 shares@ US$622.180.0000% mcap0.2% of flowCommon StockSEC:0000097745-26-000161:0
116.04 shares@ US$622.180.0000% mcap0.2% of flowCommon StockSEC:0000097745-26-000161:1
105.403 shares@ US$622.180.0000% mcap0.2% of flowCommon StockSEC:0000097745-26-000161:2
85.096 shares@ US$622.180.0000% mcap0.2% of flowCommon StockSEC:0000097745-26-000161:3
724.766 shares@ US$622.180.0002% mcap0.2% of flowCommon StockSEC:0000097745-26-000167:0
531.851 shares@ US$622.180.0001% mcap0.2% of flowCommon StockSEC:0000097745-26-000167:1
10.567 shares@ US$622.180.0000% mcap0.7% of flowCommon StockSEC:0000097745-26-000163:0
12.915 shares@ US$622.180.0000% mcap0.8% of flowCommon StockSEC:0000097745-26-000163:1
11.447 shares@ US$622.180.0000% mcap0.7% of flowCommon StockSEC:0000097745-26-000163:2
14.97 shares@ US$622.180.0000% mcap1.0% of flowCommon StockSEC:0000097745-26-000163:3
44.483 shares@ US$622.180.0000% mcap14.8% of flowCommon StockSEC:0000097745-26-000166:1
19.824 shares@ US$622.180.0000% mcap6.6% of flowCommon StockSEC:0000097745-26-000166:2
55.12 shares@ US$622.180.0000% mcap18.3% of flowCommon StockSEC:0000097745-26-000166:3
113.623 shares@ US$622.180.0000% mcap37.7% of flowCommon StockSEC:0000097745-26-000166:4
4,133 shares@ US$614.380.0010% mcap27.6% of flowCommonSEC144:0001959173-26-006539
275 shares@ US$309.630.0000% mcap0.0% of flowCommon StockSEC:0001216055-26-000012:0
101 shares@ US$625.410.0000% mcap0.0% of flowCommon StockSEC:0001216055-26-000012:1
33 shares@ US$626.590.0000% mcap0.0% of flowCommon StockSEC:0001216055-26-000012:2
79 shares@ US$628.010.0000% mcap0.0% of flowCommon StockSEC:0001216055-26-000012:3
62 shares@ US$628.740.0000% mcap0.0% of flowCommon StockSEC:0001216055-26-000012:4
275 shares@ US$627.04780.0001% mcap0.1% of flowCommonSEC144:0001959173-26-006401
909 shares@ US$625.450.0002% mcap0.3% of flowCommon StockSEC:0000097745-26-000152:1
1,791 shares@ US$627.390.0004% mcap0.6% of flowCommon StockSEC:0000097745-26-000152:13
10,000 shares@ US$309.630.0012% mcap1.6% of flowCommon StockSEC:0000097745-26-000152:0
25 of 2318 declarations
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc., a US healthcare company valued at USD 254 billion, shows 1,158 sales worth EUR 1,135,078,520 (median EUR 477,351) and only 3 purchases, EUR 12,245 in total: the largest, EUR 8,287, is Nelson Chai's (Director) on November 7, 2024, with EUR 2,029 for Chai on December 9, 2024 and EUR 1,929 for Michael A. Boxer (SVP and General Counsel) on June 26, 2023.
Marc N. Casper signs 1,076 of the 2,318 filings, 850 of them sales and none a purchase. Filed as Chief Executive Officer, Casper sold EUR 26,833,121 on October 1, 2018, the largest sale on record. Michel Lagarde (Executive Vice President & COO) sold EUR 15,039,722 on December 2, 2025 and EUR 14,788,548 the next day. Stephen Williamson (Retiring Sr. VP and CFO) has 163 filings, Michel Lagarde 138 and Mark Stevenson (Retiring Executive VP & COO) 135.
Read moreShow less
There are 836 grants and 222 option exercises. Annual volume rises to 343 in 2022 and 332 in 2024. The last twelve months hold 251 filings, of which 156 sales and no purchase.
